|
|
The relationship between the CYP3A5 genetic polymorphisms and susceptibility to childhood acute leukemia |
Department of Hematology, Yuying Children’s Hospital, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027
|
|
Cite this article: |
HUANG Zhen,CHEN Min,ZENG Weiwei, et al. The relationship between the CYP3A5 genetic polymorphisms and susceptibility to childhood acute leukemia[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2014, 44(10): 733-736.
|
|
Abstract Objective: To study the relationship of CYP3A5-6986A/G polymorphism and acute leukemia in Han population of southern Chinese. Methods: The methods of polymerase chain reaction-restriction fragment length polymorphism and PCR sequence were used, the polymorphism of the CYP3A5 gene was detected in both 119 acute leukemia patients and 106 control subjects. Results: ①The differences in the distribution of genotype of CYP3A5-6986A/G between the patients and the controls were significant. ②The genetic frequency of G allele in ALL and in AML were all higher than that in controls. ③The results by gender stratification showed that the boy individuals with CYP3A5 variant genotype were more susceptible to childhood leukemia with a 2.65-fold increased risk compared to the individuals with wild genotype. ④There was no variation of CYP3A5-6986A/G polymorphism on acute leukemia patients between Wenzhou and Suzhou area. Conclusion: The CYP3A5 genetic polymorphism may be associated with the susceptibility of acute leukemia in Han population of male southern Chinese.
|
Received: 27 November 2013
|
|
|
|
|
[1]Canalle R, Burim RV, Tone LG, et al. Genetic polymor-phisms and susceptibility to childhood acute lymphoblastic leukemia[J]. Environ Mol Mutagen, 2004, 43(2):100-109.
[2]Krajinovic M, Labuda D, Sinnett D, et al. Childhood acute lymphoblastic leukemia: genetic determinants of susceptibil-ity and disease outcome[J]. Rev Environ Health, 2001, 16(4): 263-279.
[3]中华医学会儿科学分会血液学组. 儿童急性淋巴细胞白血病诊疗建议[J]. 中华儿科杂志, 2009, 5(44): 392-395.
[4]黄珍, 柴忆欢, 岑建农, 等. CYP3A5基因多态性与儿童急性白血病的相关性研究[J].中华儿科杂志, 2007, 45(7):546-548.
[5]Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of poly-morphic CYP3A5 expression[J]. Nat Genet, 2001, 27(4):383-391.
[6]Simpson D, Noble S. Tacrolimus ointment: A review of its use in atopic dermatitis and its clinical potential in other in-flammatory skin conditions[J]. Drugs, 2005, 65(6): 827-858.
[7]Li D, Zhang GL, Lou YQ, et al. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kacakh ethnic groups[J]. J Clin Pharm Ther, 2007, 32(1): 89-95.
[8]van Schaik RH, van der Heiden IP, van den Anker JN, et al. CYP3A5 variant allele frequencies in Dutch Caucasians[J].Clin Chem, 2002, 48(10): 1668-1671.
[9]Pakakasama S, Mukda E, Sasanakui W, et al. Polymorphisms of drug metabolizing enzymes and risk of acute lymphoblas-tic leukemia[J]. Am J Hematol, 2005, 79(3): 202-205.
[10]Liu TC, Lin SF, Chen TP, et al. Polymorphism analysis of CYP3A5 in myeloid leukemia[J]. Oncol Rep, 2002, 9(2): 327-329.
[11]沈莉菁, 陈芳源, 王婷, 等. CYP3A5基因多态性及其在急性白血病患者化疗与预后中的意义[J]. 中国实验血液学杂志, 2008, 16(1): 26-30.
[12]Hu YF, He J, Chen GL, et al. CYP3A5*3 and CYP3A4*18single nucleotide polymorphisms in a Chinese population[J].Clin Chim Acta, 2005, 353(1-2): 187-192.
[13]Sinues B, Mayayo E, Fanle A, et al. Effect of growth hor-mone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children[J]. Eur J Clin Pharmacol, 2004, 60(8): 559-564. |
|
|
|